These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3048123)

  • 1. Lack of efficacy of pindolol in tardive dyskinesia.
    Greendyke RM; Webster JC; Kim J; Kim H
    Am J Psychiatry; 1988 Oct; 145(10):1318-9. PubMed ID: 3048123
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone in tardive dyskinesia.
    Blum I; Nisipeanu PF; Roberts E
    Psychopharmacology (Berl); 1987; 93(4):538. PubMed ID: 3124188
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
    J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone and naltrexone in mental illness and tardive dyskinesia.
    Volavka J; Anderson B; Koz G
    Ann N Y Acad Sci; 1982; 398():97-102. PubMed ID: 6760771
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
    Alpert M; Friedhoff AJ; Diamond F
    Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose pyridoxine in tardive dyskinesia.
    DeVeaugh-Geiss J; Manion L
    J Clin Psychiatry; 1978 Jun; 39(6):573-5. PubMed ID: 350860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of baclofen on tardive dyskinesia.
    Gerlach J; Rye T; Kristjansen P
    Psychopharmacology (Berl); 1978 Mar; 56(2):145-51. PubMed ID: 417365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxypertine in tardive dyskinesia: an 8-week controlled study.
    Soni SD; Freeman HL; Hussein EM
    Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
    J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin precursor effects in tardive dyskinesia.
    Nasrallah HA; Smith RE; Dunner FJ; McCalley-Whitters M
    Psychopharmacology (Berl); 1982; 77(3):234-5. PubMed ID: 6812144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report of adverse effect of reserpine on tardive dyskinesia.
    Donatelli A; Geisen L; Feuer E
    Am J Psychiatry; 1983 Feb; 140(2):239-40. PubMed ID: 6129810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable clinical response to choline in tardive dyskinesia.
    Nasrallah HA; Dunner FJ; Smith RE; McCalley-Whitters M; Sherman AD
    Psychol Med; 1984 Aug; 14(3):697-700. PubMed ID: 6387757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulpiride in tardive dyskinesia.
    Casey DE; Gerlach J; Simmelsgaard H
    Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of lithium treatment in established tardive dyskinesia.
    MacKay AV; Sheppard GP; Saha BK; Motley B; Johnson AL; Marsden CD
    Psychol Med; 1980 Aug; 10(3):583-7. PubMed ID: 7003639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tardive dyskinesia: etiology, clinical features and therapy].
    Furer V; Lichtenberg P; Heresco-Levy U
    Harefuah; 2001 Mar; 140(3):248-52. PubMed ID: 11303354
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
    Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
    Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sodium valproate on tardive dyskinesia--revisited.
    Fisk GG; York SM
    Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatments of tardive dyskinesia in the 1980s.
    Jeste DV; Lohr JB; Clark K; Wyatt RJ
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):38S-48S. PubMed ID: 3065364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
    Müller T
    Expert Opin Investig Drugs; 2015 Jun; 24(6):737-42. PubMed ID: 25809133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
    Quinn N; Marsden CD
    J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.